TY  - CHAP
AU  - Na Li
AU  - Xiaohan Zhan
AU  - Xianquan Zhan
ED  - Sinem Nalbantoglu
ED  - Hakima Amri
Y1  - 2018-11-05
PY  - 2018
T1  - Energy Metabolism Heterogeneity-Based Molecular Biomarkers for Ovarian Cancer
N2  - Molecular medicine is an applied science focused on human genes/transcripts, proteins, metabolites, and metabolic networks that describes molecular and cellular processes of health and disease onset and progression. Molecular medicine-based integrative identification and characterization of biomarker targets and their clinical translations is essential to explain/decipher the mechanism(s) underlying physiological pathways and pathological conditions, and acquire cell-targeted early interventional and therapeutic strategies in the context of precision medicine and public health.  Principally, Molecular Medicine provides an overview of the latest headlines/developments of systems and molecular medicine, highlighting the emerging high-throughput technologies, promising potential applications, and progress in biomedical research and development strategies.
BT  - Molecular Medicine
SP  - Ch. 5
UR  - https://doi.org/10.5772/intechopen.80622
DO  - 10.5772/intechopen.80622
SN  - 978-1-83962-760-6
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-19
ER  -